Search
Isoflurophate Action Pathway (new)
smpdb.ca/view/SMP0126686Drug actionIsoflurophate is a cholinesterase inhibitor used to treat glaucoma, as it acts as a powerful miotic agent constricting the pupil and causing the aqueous fluid to flow out and relieve pressure. It acts by irreversibly binding to acetylcho...
Enzymes: High affinity choline transporter 1Demecarium Action Pathway (new)
smpdb.ca/view/SMP0126687Drug actionDemecarium is a cholinesterase inhibitor used in the treatment of glaucoma, acting as an indirect parasympathomimetic agent by increasing acetylcholine levels in the synaptic cleft. The mechanism of action is demecarium the drug acts on ...
Enzymes: High affinity choline transporter 1Rivastigmine Action Pathway (new)
smpdb.ca/view/SMP0126688Drug actionRivastigmine is a cholinesterase inhibitor used in the treatment of symptoms of dementia in Alzheimer's and Parkinson's. The drug reversible binds to and inhibits acetylcholinesterase and cholinesterase which stops the breakdown of acety...
Enzymes: High affinity choline transporter 1Echothiophate Action Pathway
smpdb.ca/view/SMP0126704Drug actionEchothiophate also known as phospholine iodide is an acetylcholinesterase inhibitor, used in the treatment of glaucoma in order to increase the drainage of intraocular fluid. It is administered via eye drops and acts on acetylcholinester...
Enzymes: High affinity choline transporter 1Phenserine Action Pathway
smpdb.ca/view/SMP0126724Drug actionPhenserine is a next-generation acetylcholinesterase, used to treat dementia. It acts as a highly selective reversible acetylcholinesterase inhibitor, which is known to increase acetylcholine levels in the synaptic cleft and enhance the ...
Enzymes: High affinity choline transporter 1CX-046684
go.drugbank.com/drugs/DB19414ApprovedCX-046684 is a COVID-19 mRNA vaccine encoding the pre-fusion stabilized Spike glycoprotein (S) of the SARS-CoV-2 Omicron variant lineage KP.2. It is the active ingredient of the 2024-2025 formulation of Moderna's Spikevax vaccine.
Diltiazem
go.drugbank.com/drugs/DB00343ApprovedInvestigationalIt works through various mechanisms of action, but it primarily works by inhibiting the calcium influx into cardiac and vascular smooth muscle during depolarization. … Approved in 1982 by the FDA, it is a member of the non-dihydropyridine calcium channel blockers drug class.
Eletriptan
go.drugbank.com/drugs/DB00216ApprovedInvestigationalEletriptan is a second generation triptan drug developed by Pfizer Inc for the treatment of migraine headaches.
Prednisolone acetate
go.drugbank.com/drugs/DB15566ApprovedInvestigationalVet approvedPrednisolone acetate is a [prednisolone] molecule bound to an acetate functional group by an ester bond.[L9449] Prednisolone acetate was granted FDA approval in 1955.[L9449]
Tedizolid phosphate
go.drugbank.com/drugs/DB09042Approved[L11232, A199086, A199050] Tedizolid was approved by the FDA on June 20, 2014, for sale by Cubist Pharmaceuticals as tedizolid phosphate (SIVEXTRO®).